CBRS Cerebras Systems Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 2021728 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA—
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets23.3%
Debt / equity0.09x
Current ratio5.27x
Interest coverage—
Cash quality & payout
Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $210.81M | $180.11M | $193.41M | $135.71M | $103.32M | $99.51M |
| Cost of revenue | $168.72M | $154.55M | $107.23M | $80.58M | $71.22M | $57.91M |
| Gross profit | $42.09M | $25.56M | $86.18M | $55.13M | $32.10M | $41.60M |
| R&D expense | $177.84M | $320.15M | $75.50M | $57.26M | $60.77M | $52.75M |
| SG&A expense | $55.59M | $95.67M | $11.02M | $3.51M | $10.29M | $7.00M |
| Operating income | -$224.15M | -$477.23M | -$15.04M | -$26.47M | -$57.18M | -$28.47M |
| Pretax income | -$160.25M | -$450.25M | -$12.51M | -$20.68M | $311.18M | -$22.18M |
| Income tax | $969,000 | $274,000 | $1.50M | $1.52M | $1.66M | $1.68M |
| Net income | -$161.22M | -$450.53M | -$14.01M | -$22.20M | $309.51M | -$23.87M |
| EBITDA | -$194.35M | -$452.86M | $3.14M | -$17.84M | -$51.58M | -$24.56M |
| EPS (basic) | -0.67 | -2.98 | -0.22 | -0.41 | 2.28 | -0.46 |
| EPS (diluted) | -0.67 | -2.98 | -0.22 | -0.41 | 1.91 | -0.46 |
| Weighted avg. shares (diluted) | 238.88M | 150.97M | 62.81M | 53.98M | 161.82M | 52.00M |
| Balance sheet | ||||||
| Cash & equivalents | $3.07B | $6.74B | $1.72B | $1.33B | $376.89M | $472.01M |
| Short-term investments | $4.29B | $1.18B | $515.61M | — | — | — |
| Receivables | $231.76M | $123.36M | $62.63M | — | — | — |
| Inventory | $146.10M | $32.67M | $89.04M | — | — | — |
| Current assets | $8.87B | $9.12B | $3.58B | — | — | — |
| PP&E, net | $1.51B | $986.81M | $572.44M | — | — | — |
| Total assets | $11.94B | $11.63B | $4.95B | — | — | — |
| Current liabilities | $1.68B | $1.57B | $1.43B | — | — | — |
| Short-term debt | $706.52M | $736.04M | $621.31M | — | — | — |
| Long-term debt | $122.56M | $182.21M | $361.62M | — | — | — |
| Total debt | $829.08M | $918.24M | $982.92M | — | — | — |
| Total liabilities | $2.78B | $2.47B | $2.20B | — | — | — |
| Shareholders' equity | $9.16B | $9.15B | -$194.68M | -$656.89M | -$651.12M | -$978.21M |
| Net debt | -$2.25B | -$5.82B | -$733.09M | — | — | — |
| Cash flow statement | ||||||
| Operating cash flow | -$341.41M | -$59.82M | $12.34M | -$10.37M | -$68.91M | -$54.94M |
| Capital expenditure | $497.19M | $416.90M | $131.97M | $116.05M | $86.85M | $98.24M |
| Free cash flow | -$838.59M | -$476.73M | -$119.64M | -$126.42M | -$155.76M | -$153.18M |
| Investing cash flow | -$3.58B | -$1.07B | -$236.62M | -$95.43M | -$30.55M | -$56.75M |
| Financing cash flow | $16.18M | $5.82B | $2.04B | $1.06B | $3.60M | $1.55M |
| Depreciation & amortization | $29.79M | $24.38M | $18.18M | $8.62M | $5.60M | $3.91M |
| Stock-based compensation | $155.10M | $377.01M | $9.59M | $11.35M | $13.28M | $9.15M |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.